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Clostridium difficile is a leading cause of antibiotic-
associated diarrhea. The mechanisms underlying
C. difficile expansion after microbiota disturbance
are just emerging. We assessed the gene expression
profile ofC. difficilewithin the intestine of gnotobiotic
mice to identify genes regulated in response to either
dietary or microbiota compositional changes. In the
presence of the gut symbiont Bacteroides thetaio-
taomicron, C. difficile induces a pathway that me-
tabolizes the microbiota fermentation end-product
succinate to butyrate. The low concentration of
succinate present in the microbiota of conventional
mice is transiently elevated upon antibiotic treatment
or chemically induced intestinal motility disturbance,
andC. difficile exploits this succinate spike to expand
in the perturbed intestine. A C. difficile mutant
compromised in succinate utilization is at a competi-
tive disadvantage during these perturbations. Under-
standing the metabolic mechanisms involved in
microbiota-C. difficile interactions may help to iden-
tify approaches for the treatment and prevention of
C. difficile-associated diseases.
INTRODUCTION
One of the most common causes of infectious antibiotic-associ-
ated diarrhea is the Gram-positive, spore-forming anaerobe
Clostridium difficile (He et al., 2013). While C. difficile resides
asymptomatically in the gastrointestinal tract of 2%–5% of the
population, it can also cause pathology ranging from mild diar-
rhea to severe colitis, toxic megacolon, and other C. difficile-
associated diseases (CDAD) (Rivera and Woods, 2003). Even
after successful treatment with antibiotics such as vancomycin
or metronidazole, roughly 20%–30% of individuals experience
disease recurrence (Pepin, 2006; Johnson, 2009). Fecal trans-
plants have been found to be effective in curing recurrent
CDAD, consistent with the importance of a healthy gut
ecosystem in outcompeting C. difficile (Khoruts et al., 2010;770 Cell Host & Microbe 16, 770–777, December 10, 2014 ª2014 ElsvanNood et al., 2013). The successful use of six bacterial species
to cure persistent infection inmice, but failure of other cocktails of
six or fewer species, underscores thecurrent poor understanding
of ecological relationships that underlie C. difficile disease (Law-
ley et al., 2012). Additionalmechanistic insight into howC.difficile
exploits the perturbed gut ecosystem will facilitate prevention
strategies to hold C. difficile at bay during the period of postanti-
biotic vulnerability (Wilson and Perini, 1988; Ng et al., 2013).
The gutmicrobiotametabolizes dietary and host-derived nutri-
ents and produces end products, including heat, gases, organic
acids (OAs) and short-chain fatty acids (SCFAs). Of all metabo-
lites in the colon, dietary carbohydrates play the largest role in
the formation of SCFAs and OAs (Macfarlane and Macfarlane,
2003). The SCFAs acetate, propionate, and butyrate are the
most common end products of fermentation within the gut mi-
crobiota (Wong et al., 2006). The OAs succinate and lactate
are also common end products of primary fermenters that are
taken up and metabolized by other microbes. Several recent
studies have highlighted the role of the microbiota-produced
metabolites in pathogen colonization (Thiennimitr et al., 2011;
Ng et al., 2013; Maier et al., 2013); however, the contribution of
SCFAs and OAs on pathogenesis remains understudied (Curtis
et al., 2014). While antibiotics contribute to the majority of cases
of hospital-acquired C. difficile, dietary and motility changes
represent two unexplored perturbations that may contribute to
cases of community-acquired C. difficile infection that occur
independently of antibiotic exposure (Wilcox et al., 2008; Khanna
and Pardi, 2012). Shifts in diet have been shown to affect the
composition and diversity of the microbiota (Turnbaugh et al.,
2009; Wu et al., 2011; McNulty et al., 2013), and the extent
to which diet-induced transitions in microbiota membership
share ecosystem disturbance characteristics with antibiotic
use is unknown. C. difficile and other opportunistic members
of the microbiota have evolved mechanisms to capitalize on
such ecosystem alterations (Lozupone et al., 2013; Ng et al.,
2013). In our previous study, microbiota liberation of the host
mucosal monosaccharide sialic acid was identified as a nutrient
source used by C. difficile and Salmonella during postantibiotic
expansion (Ng et al., 2013). Further characterization of how
microbiota perturbations affect availability of metabolites that
contribute to pathogen niches is needed.
In this study, we aimed to understand the mechanisms
underlying C. difficile expansion after microbiota disturbance,evier Inc.
Figure 1. Metabolic Strategies Employed
by C. difficile in Response to a Human Gut
Commensal
(A) C. difficile density in feces at 1 day post-
infection of GF (Cd) or Bt-associated mice (Cd +
Bt) and fed standard diet (Std diet) or poly-
saccharide-deficient diet (Pd diet) (n = 4 per
group). Error bars represent SD.
(B) C. difficile catabolic pathways with significant
differences in gene expression levels in vivo in
the presence and absence of Bt. Mice were fed
standard diet (Std) or polysaccharide-deficient
diet (Pd). Colors indicate the deviation of each
gene’s signal above (purple) and below (green) its
mean (black) expression value across all sixteen
in vivo samples (n = 4 per group) at 5 days post-
infection in cecal contents. Fold change values
correspond to gene expression in the Bt-biasso-
ciation relative to the monoassociation state.
(C) Concentration of the SCFA butyrate in cecal
contents of standard diet-fed mice colonized with
Bt,C. difficile and Bt (Cd + Bt), orC. difficile (Cd) at
5 days postinfection (n = 4 per group). Error bars
represent SD.
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lized germ-free (GF) mice colonized with a well-character-
ized representative of the prominent Bacteroides genus,
B. thetaiotaomicron (Bt). We profiled the transcriptional
response elicited by C. difficile in the presence and absence
of Bt in vivo using standard polysaccharide-rich dietary condi-
tions versus a polysaccharide-deficient diet. We identified key
metabolic strategies that C. difficile differentially regulates
in these environmental conditions. Bt produces high levels of
succinate during fermentation of dietary carbohydrates, and
C. difficile couples reduction of succinate to butyrate with
fermentation of remaining dietary carbohydrates. C. difficile
relies on succinate in a conventional, antibiotic-treated setting
as well as after gut motility disturbance to efficiently expand.
This work sheds light on the important roles that microbiota-
associated metabolites play in C. difficile expansion, which
has implications for potential therapeutic strategies for enteric
pathogens.Cell Host & Microbe 16, 770–777, DRESULTS
Identification of Key Metabolic
Strategies for C. difficile
Colonization In Vivo
We sought to identify colonization strate-
gies employed by C. difficile within the
gut. When C. difficile infects mice colo-
nized with Bt, it attains higher population
densities on day 1 postinfection when the
mice were fed a polysaccharide-rich
standard diet (2.1-fold). Previous work
has shown that C. difficile obtains higher
population densities in the presence of
Bt in polysaccharide-deficient chow (Ng
et al., 2013) (Figure 1A). We performed
transcriptional profiling of C. difficileresiding within the distal gut of gnotobiotic mice in these four
conditions to identify potential metabolic strategies employed
by C. difficile in the presence of Bt that could explain its ability
to attain higher densities (Figure 1B). Five clusters of orthologos
groups functional categories, including ‘‘carbohydrate transport
and metabolism,’’ are significantly differentially regulated (p <
0.01; hypergeometric test) in response to the presence of Bt
and three categories changed in response to polysaccharide
availability in the diet (Figures S1A and S1B available online).
Several putative operons involved in nutrient acquisition and
metabolism are responsive to changes in the gut environment.
C. difficile expresses the sialic acid utilization pathway more
highly in the Bt-bicolonized condition when mice are fed a poly-
saccharide-deficient diet (14.8- to 88-fold), consistent with our
previous report (Ng et al., 2013) (Figure 1B; Table S1). In some
cases, the changes are specific to a colonization state in a single
dietary condition. For instance, utilization pathways of sorbitol
and fructose, both common dietary sugars found in many plantsecember 10, 2014 ª2014 Elsevier Inc. 771
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condition when mice are fed standard diet, whereas the glucose
utilization operon is more highly expressed in all other conditions
(Figure S1C). Dietary change also affectsC. difficile gene expres-
sion, and in standard diet, genes involved in sorbitol/glucitol
utilization and cell-surface modification increase, whereas in
polysaccharide-deficient diet, genes involved in acquiring cofac-
tors such as cobalt and iron as well as cell-surface proteins and
sugar ABC transporters increase (Table S1). Because the genes
involved in the conversion of succinate to butyrate were highly
expressed in conditions where C. difficile achieves higher
density (4.9- to 8.2-fold increase in expression in the Bt-biasso-
ciation relative to monoassociation) (Figures 1B, S1D, and S1E;
Table S1), we pursued the importance of this pathway for gut
colonization by C. difficile.
C. difficile Relies on Microbiota-Produced Succinate to
Expand in the Intestine
A similar succinate-to-butyrate pathway has been described for
Clostridium kluyveri (Kenealy and Waselefsky, 1985; Wolff et al.,
1993), which enables regeneration of NAD+ from nicotinamide
adenine dinucleotide. Succinate metabolism does not directly
yield ATP; however, it acts as an electron sink, allowing for
the oxidation of electron carriers (Wolff et al., 1993). Notably,
C. difficile’s induction of this NAD+ regenerating pathway is coin-
cidently expressed with genes that enable consumption of the
sugar alcohol, sorbitol, as well as other dietary sugars, including
fructose, which require NAD+ for catabolism (Figure S2). We
quantified the levels of SCFAs and OAs in the four in vivo condi-
tions (Figures S3A and S3B). In monoassociation, Bt produces
high levels of succinate (Figure S3A). Succinate is a common
by-product of primary fermenters such as Bt and is typically
consumed by various secondary fermenters in the gut (Fisch-
bach and Sonnenburg, 2011). In Bt biassociation, C. difficile
produced higher levels of butyrate compared with its monoasso-
ciation (3.8-fold, p < 0.01) (Figure 1C), consistent with its use of
Bt-generated succinate to produce butyrate.
We next tested the metabolic role of the putative C. difficile
succinate-to-butyrate pathway. Using ClosTron-targeted muta-
genesis (Heap et al., 2010), we mutated CD2344, a putative
succinate transporter, of C. difficile, creating the mutant strain
Cd-CD2344. Although both WT and the mutant strain grow
equally well in minimal medium (MM) containing glucose or
water (Figure 2A), Cd-CD2344 is unable to use succinate for
growth (Figure 2A). Gas chromatography mass spectrometry
(GC-MS) measurement of SCFAs within the medium from the
cultures at the maximum optical density revealed that
C. difficile WT and Cd-CD2344 show no differences in SCFA
production when grown in MM glucose (Figures 2B and S3C).
The mutant Cd-CD2344 produces significantly less butyrate
than WT C. difficile grown in MM containing succinate (11.4-
fold, p < 0.0001) (Figure 2B) and does not deplete succinate
from the medium (5-fold, p < 0.05) (Figure 2C). When
C. difficile and Cd-CD2344 are grown in MM containing 13C-
succinate, only WT C. difficile is able to produce 13C-butyrate
(p < 0.001, Figure 2D; p < 0.05, Figure 2E), and no 13C-propio-
nate or 13C-acetate are found as byproducts, demonstrating
that this pathway is specific for the conversion of succinate to
butyrate and is not functional in the mutant strain.772 Cell Host & Microbe 16, 770–777, December 10, 2014 ª2014 ElsWe conducted several experiments to assess whether the
succinate-to-butyrate pathway is necessary for C. difficile to
expand in the presence of Bt. C. difficile-monoassociated mice
were fed a polysaccharide-deficient diet, which unlike the stan-
dard diet, is known to not include sorbitol as a component.
C. difficile is able to achieve marginally increased densities
with succinate addition in a monoassociation; however, a more
dramatic benefit is observed when succinate is administered in
the presence of the fermentable sugar alcohol, sorbitol, a com-
mon carbohydrate present in many fruits (Figure 3A). In contrast,
Cd-CD2344 does not reach high densities when colonizing GF
mice supplemented with succinate and sorbitol-containing
water (7.1-fold, p < 0.05) (Figure 3B), consistent with the inability
of the mutant to consume succinate effectively. In mice colo-
nized with succinate-producing Bt, Cd-CD2344 is unable to
reach the same densities as WT (8.8-fold, p < 0.0001) (Figures
3C and S3D) and produces lower levels of butyrate compared
with WT C. difficile (1.9-fold, p < 0.001) (Figure 3D), demon-
strating that the succinate-to-butyrate pathway is important for
C. difficile’s expansion in the presence of Bt. There are no signif-
icant differences in any other SCFAs or OAs quantified from the
cecal contents of biassociated mice (Figure S3E). Cd-CD2344
also induces less severe inflammation compared with WT
C. difficile in Bt-associated GF mice (Figure S4).
Postantibiotic Succinate Accumulation Is a Key Nutrient
for C. difficile Expansion
We next used antibiotic-treated conventional mice to deter-
mine the importance of succinate for C. difficile expansion in
the context of a complex microbiota. Antibiotic treatment of
conventional mice results in a significant reduction in the levels
of the SCFAs acetate and butyrate and a concomitant significant
increase in succinate levels (87-fold, p < 0.001) (Figure 4A).
In a competition experiment, WT C. difficile outcompetes Cd-
CD2344 (7.3-fold, p < 0.05) (Figure 4B). These data demon-
strate that succinate is one of several key nutrients promoting
C. difficile expansion after antibiotic treatment.
Microbiota-Derived Succinate Is Utilized by C. difficile
upon Nonantibiotic Perturbations
We testedwhether perturbations to the gutmicrobiota other than
antibiotics could enable C. difficile to gain access to succinate
and expand to cause disease. A significant proportion (22%–
48%) of community-acquired C. difficile infections are not asso-
ciated with recent antibiotic use (Wilcox et al., 2008; Khanna and
Pardi, 2012). Our previous work established that changes in gut
motility induced by oral polyethylene glycol (PEG) treatment
decreases diversity of the gut microbiota and significantly in-
creases the presence of members of the family Peptostrepto-
coccaceae, the same family that includes C. difficile (Kashyap
et al., 2013). Given that members of the same family often share
general metabolic characteristics, we wondered whether PEG-
induced motility disturbance could share molecular features
with antibiotic disturbance and result in C. difficile infection.
Mice were administered a 10% PEG solution in drinking water,
resulting in mild diarrhea and reduced gastrointestinal transit
time (Kashyap et al., 2013). After 5 days of PEG treatment,
mice were infected withC. difficile.C. difficile efficiently expands
within the gut of mice with PEG-induced diarrhea (Figure 4C),evier Inc.
Figure 2. A C. difficile Operon Encodes Succinate-to-Butyrate Conversion
(A) Growth ofWTC. difficile (Cd) andCD2344mutantC. difficile (Cd-CD2344) in MMcontaining 1%glucose (left), water (center), or 0.1% succinate (right). OD600
measurements were taken every 30 min (n = 3 per group). Representative of at least three replicates.
(B) Concentrations of butyrate produced after growth ofCd orCd-CD2344 in MM containing 0.5% glucose (MM + glucose) or 0.1% succinate (MM + succinate)
(n = 3 per group). Error bars represent SD.
(C) Concentrations of succinate remaining after growth of Cd or Cd-CD2344 in MM containing 0.5% glucose (MM + glucose) or 0.1% succinate (MM + suc-
cinate) (n = 3 per group). Error bars represent SD.
(D) Levels of 13C-butyrate produced by Cd or Cd-CD2344 in MM containing 0.5% glucose (MM + glucose) or 0.1% 13C-succinate (MM + succinate) (n = 3 per
group). Error bars represent SD.
(E) Levels of 13C-succinate remaining after growth ofCd orCd-CD2344 in minimal media containing 0.5% glucose (MM+ glucose) or 0.1% 13C-succinate (MM+
succinate) (n = 3 per group). Error bars represent SD.
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Figure 3. C. difficile Consumes the Bt
Fermentation Product Succinate to Expand
in the Intestinal Ecosystem
(A) C. difficile density in feces at 2 days post-
infection of GF mice fed a standard diet (Std) or
polysaccharide-deficient diet (Pd), supplemented
with water containing 1% sorbitol (Sor), 1% suc-
cinate (Suc), or both 1%sorbitol and 1%succinate
(Sor + Suc) (n = 5 per group). **** indicates statis-
tical significance at an alpha value of <0.05 by
one-way ANOVA with Bonferroni multiple com-
parisons test. Error bars represent SD.
(B) C. difficile density in feces of GF mice
consuming polysaccharide-deficient diet and in-
fected with WT C. difficile (Cd) or Cd-CD2344
mutant C. difficile (Cd-CD2344) and adminis-
tered water () or water containing 1% sorbitol
and 1% succinate (+) at 1 day postinfection (n = 5
per group). Error bars represent SD.
(C) C. difficile density in feces of Bt-associated
mice infected with WT C. difficile (Bt + Cd)
or Cd-CD2344 mutant C. difficile (Bt + Cd-
CD2344) at day 1 postinfection and under stan-
dard dietary conditions (n = 5 per group). Error
bars represent SD.
(D) Concentration of butyrate in cecal contents
of Bt-associated mice infected with WT
C. difficile (Cd) or Cd-CD2344 mutant C. difficile
(Cd-CD2344) at day 3 postinfection and under
standard dietary conditions (n = 5 per group). Error
bars represent SD.
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otic treatment (Ng et al., 2013). Diarrhea reduces the levels of
butyrate and acetate and increases succinate (80-fold, p <
0.01) (Figure 4D), mirroring the changes that occur after antibi-
otic treatment. In competition, WT C. difficile outcompetes Cd-
CD2344 in the presence of PEG (16.4-fold, p < 0.05) (Figure 4B),
although in single infections of antibiotic-treated mice, Cd-
CD2344 reached similar density levels as WT C. difficile (Fig-
ure S4C). These results demonstrate that succinate and other
nutrients promote the expansion of C. difficile in the presence
of PEG-induced diarrhea.
DISCUSSION
Our results demonstrate that C. difficile relies on the micro-
biota-produced metabolite succinate after antibiotic treatment
as well as after the induction of diarrhea to efficiently expand
and cause disease. The ability of C. difficile to reach high den-
sities in the gut via pools of microbiota-produced metabolites
is consistent with our previous work showing that both
C. difficile and Salmonella typhimurium rely on microbiota liber-
ation of the host mucosal monosaccharide, sialic acid, as a
nutrient source during postantibiotic expansion (Ng et al.,
2013). The succinate utilization pathway that C. difficile upre-
gulates regenerates NAD+. In other studies, genes from both
the nan operon (CD2240 and CD2241) and the succinate-to-
butyrate pathway (CD2338, CD2339) were found to be present
in the C. difficile spore proteome (Lawley et al., 2009), consis-
tent with the utility of these pathways soon after germination.
Our transcriptional profiling screen also identified C. difficile
genes specifying an ethanolamine utilization pathway. The pre-774 Cell Host & Microbe 16, 770–777, December 10, 2014 ª2014 Elsvious report of ethanolamine metabolism by Salmonella within
the gut suggests that metabolic strategies common to the anti-
biotic-associated pathogens likely extend beyond the ones
identified (Thiennimitr et al., 2011). Building an understanding
of the hierarchy and relative importance of nutritional sub-
strates used by antibiotic-associated pathogens is an impor-
tant goal of future work.
Metabolomics studies on antibiotic-treated communities have
shown that there are dramatic differences in host responses, bile
acid composition, SCFA levels, and carbohydrate availability af-
ter antibiotic treatment (Antunes et al., 2011; Theriot et al., 2014).
Our work reveals that C. difficile responds to these changes by
adjusting its metabolic pathways. The well-described role of
diet in dictating fermentation products of the gut microbes,
such as SCFAs and OAs, implies a potential additional link be-
tween our food and pathogen susceptibility. The OA succinate
is not typically detected in the large intestine of healthy humans.
However, succinate has been shown to accumulate in the large
intestine of pigs with antibiotic-associated diarrhea (Tsukahara
and Ushida, 2002). Combined with the elevated succinate we
observe after PEG or antibiotic treatment, these data suggest
that metabolic cross-feeding between gut resident microbes
typically depletes succinate, and such interactions are disrupted
by microbiota perturbations. It is well known that diet can have a
profound impact on gut motility changes, and we have previ-
ously shown in a humanized mouse model that diet-induced
motility changes are accompanied by large changes in SCFA
profiles within the microbiota (Kashyap et al., 2013). How dietary
interventions may promote or ameliorate CDAD is currently un-
known, although dietary strategies that alter the composition
and metabolic capabilities of the microbiota have provenevier Inc.
Figure 4. C. difficile Exploits a Spike in Succinate Availability after
Microbiota Perturbations
(A) Concentrations of acetate, butyrate, propionate, lactate, and succinate
detected in cecal contents of streptomycin-treated conventional mice before
treatment (Conv) and 3 days after antibiotic treatment (Abx) (n = 5 per group).
Error bars represent SD.
(B) DNA of WT C. difficile (Cd) versus Cd-CD2344 mutant C. difficile
(Cd-CD2344) in feces of conventional mice treated with antibiotics (Abx) or
PEG 3 days after infection with a 1:1mixture of the two strains (n = 5 per group).
*p < 0.05, one-sample t test versus a theoretical mean of 1.0. Error bars
represent SD.
(C) C. difficile density in feces of conventional (Conv) or PEG-treated mice
infected with WT C. difficile at day 3 postinfection (n = 5 in Conv and n = 4 in
PEG). The dotted line represents the detection limit. Error bars represent SD.
(D) Concentrations of acetate, butyrate, propionate, lactate, and succinate
detected in cecal contents of PEG-treated conventional mice before treat-
ment (Conv) and 3 days after treatment (PEG) (n = 5 per group). Error bars
represent SD.
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1996; Ramakrishna et al., 2000; Muir et al., 2004; Alam et al.,
2005; Alvarez-Acosta et al., 2009; Rabbani et al., 2009). Our
data demonstrate that dietary change can rewire cross-feeding
relationships relevant to pathogen expansion. Upon ecosystem
disturbance, the identity of available nutrients depends on diet:
C. difficile is able to capitalize upon available mucus-derived
sialic acids in polysaccharide-deficient dietary conditions andCell Host &high levels of succinate in the presence of a polysaccharide-
rich diet.
This work points to common molecular features of gut micro-
biota disturbances, which create vulnerability to C. difficile
expansion. Important questions include which alterations within
the dynamic environment of the gut qualify as a ‘‘disturbance’’
and what are the common and specific molecular correlates of
different disturbances (Antunes et al., 2011; Theriot et al.,
2014). Microbiota-encoded metabolic pathways and the small
molecules they produce represent therapeutic targets to prevent
or combat C. difficile diseases.
EXPERIMENTAL PROCEDURES
Animal Diets and Treatments
GF Swiss-Webster mice of 6–8 weeks of age were utilized for experiments. All
experiments were in accordance with the administrative panel on laboratory
animal care, the Stanford Institutional Animal Care and Use Committee.
Mice were fed either an autoclaved standard diet (Purina LabDiet 5K67) or
custom polysaccharide-deficient diet (BioServ) (Sonnenburg et al., 2010).
All breeder and experimental isolators were periodically assessed for GF
status by both culture-based methods (aerobic and anaerobic) as well as
16S-based PCR screens using universal primers. Sterility of multiple irradiated
custom diets from this vendor (Bio-Serv) has been monitored in the laboratory
over a 5-year span with no samples or gnotobiotic mice fed the diets testing
positive for contamination. For water supplementation experiments, succinic
acid (Acros Organics) and sorbitol (Alfa Aesar) were administered at 1%
(w/v) concentration in water after filtration through 0.22 mm Millipore filters.
All mouse experiments presented in the manuscript are representative of at
least two independent replicates of the experiment.
For antibiotic treatment, streptomycin (Sigma) was administered at a con-
centration of 20mg in 200 ml of PBS by gavage per mouse at 24 hr preinfection,
and mice were starved at 18 hr preinfection with C. difficile. For PEG treat-
ments, PEG 3350 (Miralax) was administered at a 10% concentration in the
drinking water continuously for 5 days prior to infection and removed at the
time of infection.
Bacterial Strains and Culture Conditions
Bt (VPI-5482; ATCC 29148) was grown anaerobically (6% H2, 20% CO2, 74%
N2) overnight in tryptone yeast glucose medium as previously described (Son-
nenburg et al., 2005).
C. difficile strain 630, JIR8094, and Cd-CD2344 were cultured in Brain
Heart Infusion supplemented with 5 mg/ml of yeast extract (Remel) (BHIS)
anaerobically (6% H2, 20% CO2, 74% N2). C. difficile growth curves were
generated using MM composed of Farmtech Tryptone (peptone) (EMD),
beef extract (Becton Dickinson), yeast extract (Remel), monosodium phos-
phate (EMD), and disodium phosphate (EMD). OD600 was monitored using a
BioTek PowerWave 340 plate reader (BioTek) every 30 min at 37C anaerobi-
cally (6% H2, 20% CO2, 74% N2). Fecal densities (colony-forming units) of WT
C. difficile after colonization of GF or Bt-monoassociatedmice were quantified
by duplicate sampling with 1 ml loops and subsequent dilution and spot plating
on brain heart infusion agar (Becton Dickinson) with 10% v/v of defibrinated
horse blood (Lampire Biological Laboratories) supplemented with 25 mg/l of
erythromycin. To selectively quantify C. difficile fecal densities in antibiotic-
treated conventional mice and in Bt-biassociation experiments involving
C. difficile mutants, C. difficile moxalactam norfloxacin selective agar
(CDMN) plates were utilized as previously described (Ng et al., 2013). Because
erythromycin is not preset in CDMN plates, there is no difference in the recov-
ery of Cd-CD2344 and WT C. difficile on CDMN plates.
ClosTron generation of Cd-CD2344 followed detailed protocols for tar-
geted gene disruption in C. difficile (Heap et al., 2010). SOEing PCRs with
primers IBS, EBS1d, EBS2, and EBS (Table S2) were used to assemble and
amplify the product for intron targeting to the 365/366 nucleotide region of
the CD2344 gene, as outlined in the TargeTron user manual (Sigma Aldrich).
The retargeting sequence was digested with BsrGI/HindIII and cloned into
pMTL007C-E2. The resulting plasmid was transformed into HB101/pRK24Microbe 16, 770–777, December 10, 2014 ª2014 Elsevier Inc. 775
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Aimee Shen) to generate Cd-CD2344. Integration was confirmed by PCR.
For all experiments involving Cd-CD2344, the WT isogenic background
strain, JIR8094, was used as the WT control.
Expression Analysis
Genome-wide transcriptional profiling of C. difficile was conducted using
custom-made Affymetrix GeneChips, which contain probes for all annotated
coding sequences forC. difficile strain 630 as well as intergenic regions. RNA
was purified from cecal contents and in vitro culture, and cDNA was
prepared, fragmented, and labeled as described (Sonnenburg et al., 2005).
GeneChip data were RMA-MS normalized as described and log2 trans-
formed (Ng et al., 2013). Statistical significance for differential gene expres-
sion was determined using Significance Analysis of Microarrays (Ng et al.,
2013). The delta parameter was adjusted to achieve a false discovery rate
less than 1%, and this delta value was used to select significantly regulated
genes.
Quantification of Fermentation Metabolites
Frozen cecal contents (100–300 mg) or frozen supernatants from in vitro
growth curves were resuspended in 0.1% formic acid in water (Honeywell)
and blended with a pellet pestle (Kimble chase). Acetate, butyrate, lactate,
propionate, and succinate standards were included in each run to generate
standard curves for quantification. The samples were acidified (37% HCl),
and SCFAs were extracted (500 ml diethyl ether/extraction; two cycles).
Each sample was derivatized with N-tert-butyldimethylsilyl-N-methyltrifluora-
cetamide (MTBSTFA; Sigma Aldrich) and quantified using a gas chromato-
graph (Model 7890A; Agilent Technologies) coupled to mass spectrometer
detector (Model 5975C; Agilent Technologies). Analyses were carried out in
a split mode (1:100) on a DB-5MSUI capillary column (30 m 3 0.25 mm,
0.25 mm film thickness; Agilent Technologies) using electronic impact (70 eV)
as ionization mode and scan in m/z 50–550 mass range. The column head
pressure was 12 psi. Injector, source, and quadrupole temperatures were
250C, 280C, and 150C, respectively. The GC oven was programmed as
follows: 75C held for 2 min, increased to 120C at 40C min1; 120C held
for 5 min, increased to 320C at 20C min1; and held at 320C for 7 min.
Competitive Index Analysis
DNA was extracted from feces using the Powersoil DNA Isolation kit (MoBio).
DNA quantification was conducted by quantitative PCR using SYBR Green
(ABgene) in a MX3000P thermocycler (Strategene). Levels of WT C. difficile
were quantified by amplifying a 208 base-pair region of the CD2344 gene
with the 2344F and 2344R primers (Table S2), which included the area targeted
for mutagenesis in theCd-CD2344mutant. Genomic DNA fromCd-CD2344
did not produce a band when amplified with these primers due to the insertion
of the transposon within the region. The CDEP692 transposon-specific
sequencing primer and the 2344F primer (Table S2) were used to determine
the relative concentrations of the mutant and did not amplify a band against
WT C. difficile genomic DNA. The ratio of WT to mutant bacteria was normal-
ized to the inoculum to determine the competitive index.
Statistical Analyses
The Student’s t test was used for statistical calculations involving two group
comparisons (*p < 0.05, **p < 0.01, and ***p < 0.001). For comparisons
involving multiple experimental groups, one-way ANOVA with Bonferroni mul-
tiple comparisons test was employed, with **** indicating statistical signifi-
cance at an alpha value of <0.05. Outliers were excluded from by the Grubbs’
statistical test. Error bars indicate SD, and n indicates the number of mice used
per condition.
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